DUBLIN--(BUSINESS WIRE)--Covidien Ltd. (NYSE: COV; BSX: COV) announced today that its Board of Directors has declared a quarterly cash dividend of $0.16 per common share. The dividend is payable on May 4, 2009, to shareholders of record on March 30, 2009.

ABOUT COVIDIEN

Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien manufactures, distributes and services a diverse range of industry-leading product lines in four segments: Medical Devices, Imaging Solutions, Pharmaceutical Products and Medical Supplies. With 2008 revenue of nearly $10 billion, Covidien has more than 41,000 employees worldwide in 59 countries, and its products are sold in over 140 countries. Please visit www.covidien.com to learn more about our business.

Contacts